Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.9%

54 terminated/withdrawn out of 921 trials

Success Rate

91.9%

+5.4% vs industry average

Late-Stage Pipeline

9%

79 trials in Phase 3/4

Results Transparency

51%

313 of 612 completed trials have results

Key Signals

147 recruiting313 with results34 terminated20 withdrawn

Enrollment Performance

Analytics

N/A
460(54.1%)
Phase 2
203(23.9%)
Phase 1
82(9.6%)
Phase 4
53(6.2%)
Early Phase 1
26(3.1%)
Phase 3
26(3.1%)
850Total
N/A(460)
Phase 2(203)
Phase 1(82)
Phase 4(53)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (921)

Showing 20 of 921 trials
NCT04247191Not ApplicableTerminated

Parent Intervention to Reduce College Student Drinking and Consequences

Role: collaborator

NCT06004830Phase 2Active Not Recruiting

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1

Role: collaborator

NCT06006143Phase 2Active Not Recruiting

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

Role: collaborator

NCT03294460Phase 1Recruiting

Nicotinic Receptor Genetic Variation and Alcohol Reward

Role: lead

NCT06736444Not ApplicableRecruiting

Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT)

Role: collaborator

NCT02233868Early Phase 1Completed

Brain Inflammation and Function in Alcoholism

Role: lead

NCT02311374Early Phase 1Completed

Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness

Role: lead

NCT04946851Enrolling By Invitation

Addictions Neuroclinical Assessment (ANA)

Role: lead

NCT02181569Completed

Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study

Role: collaborator

NCT06305624Not ApplicableRecruiting

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

Role: collaborator

NCT02108080Recruiting

Characterization Imaging Instruments in Alcoholics and Non-Alcoholics

Role: lead

NCT05768763Not ApplicableCompleted

SEARCH SAPPHIRE Phase B

Role: collaborator

NCT06962592Not ApplicableRecruiting

Mentor Moms+ Study

Role: collaborator

NCT02966873Phase 2Completed

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

Role: collaborator

NCT05594238Not ApplicableActive Not Recruiting

Leveraging Virtual Care Strategies to Improve Access and Treatment for Individuals With Alcohol Use Disorders

Role: collaborator

NCT07525258Not ApplicableNot Yet Recruiting

Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

Role: collaborator

NCT07325266Phase 2Recruiting

Human Laboratory Study of Apremilast for Alcohol Use Disorder

Role: lead

NCT05185440Not ApplicableRecruiting

Reducing Alcohol Involved Sexual Violence in Higher Education

Role: collaborator

NCT04523922Phase 2Active Not Recruiting

Oxytocin to Enhance Integrated Treatment for AUD and PTSD

Role: collaborator

NCT00961792Not ApplicableActive Not Recruiting

Chicago Social Drinking Project

Role: collaborator